Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Intangibles (2016 - 2026)

Bioceres Crop Solutions' Intangibles history spans 11 years, with the latest figure at $83.9 million for Q1 2026.

  • On a quarterly basis, Intangibles changed N/A to $83.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $83.9 million, a N/A change, with the full-year FY2025 number at $181.2 million, up 2.43% from a year prior.
  • Intangibles hit $83.9 million in Q1 2026 for Bioceres Crop Solutions, down from $181.2 million in the prior quarter.
  • Over the last five years, Intangibles for BIOX hit a ceiling of $181.2 million in Q2 2025 and a floor of $76.7 million in Q2 2022.
  • Historically, Intangibles has averaged $138.5 million across 5 years, with a median of $173.8 million in 2023.
  • Biggest five-year swings in Intangibles: surged 126.56% in 2023 and later rose 1.79% in 2024.
  • Tracing BIOX's Intangibles over 5 years: stood at $76.7 million in 2022, then soared by 126.56% to $173.8 million in 2023, then increased by 1.79% to $176.9 million in 2024, then rose by 2.43% to $181.2 million in 2025, then crashed by 53.7% to $83.9 million in 2026.
  • Business Quant data shows Intangibles for BIOX at $83.9 million in Q1 2026, $181.2 million in Q2 2025, and $176.9 million in Q2 2024.